Robert Dumanois

Thermo Fisher Scientific (United States)

Biochemistry, Genetics and Molecular BiologyMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer”.

Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.05.029

N/A

0DataRank · unranked

12 citations

Sheryl K. Elkin, Robert Dumanois, Daryl Pritchard, Apostolia M. Tsimberidou

Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care

JCO Oncology Practice(2024)10.1200/op.23.00601

N/A

0DataRank · unranked

30 citations

Anthony Sireci, Robert Dumanois, Daryl Pritchard, Apostolia M. Tsimberidou